Oslo, Norway In 1990 was created ODIN Forvaltning, which is appeared as Corporate Investor. The main office of represented Corporate Investor is situated in the Oslo. The company was established in Europe in Norway.
Among the most successful fund investment fields, there are Clinical Trials, Biotechnology. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Sangart. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.
The typical case for the fund is to invest in rounds with 1 participant. In the next rounds fund is usually obtained by Leucadia National.
The top activity for fund was in 2003. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in less than 2 deals every year.
| Fund Name | Location |
| American Investment Holdings | - |
| AP Ventures | England, London, United Kingdom |
| BDR IT | - |
| Beam Capital | China, Hong Kong, Hong Kong Island |
| Briggs & Stratton | United States, Wauwatosa, Wisconsin |
| Crista Galli Ventures | - |
| Danish Investment Fund | District of Columbia, United States, Washington |
| Elscint Biomedical Investment | - |
| FabFitFun | California, Los Angeles, United States |
| Galyan's Trading Company | Indiana, Plainfield, United States |
| KNOXX | Kansas, United States, Wichita |
| Nankai Electric Railway | Japan, Osaka, Osaka Prefecture |
| Polar Investments | - |
| Svoboda Capital | Chicago, Illinois, United States |
| TLD Holdings | Hamel, Minnesota, United States |
| UCLB | England, London, United Kingdom |
| YUL Ventures | Canada, Montréal, Quebec |
| ZHEFU Holding | China, Tonglu, Zhejiang |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 